<Bowser's post started us off on the topic of the high cost of drugs relative to income in other countries.

The BBC article, not surprisingly, makes the U.S. look like the usual greedy ogre in the deal.

Points that should be noted:

Allowing generic drugs to be manufactured cheaply outside the U.S. before the patent expires obviously cripples the return on investment for the drug company. It will get a lot worse when these cheap drugs start filtering back into the U.S. illegally. And they will.

Obviously, the nations who don't invent or manufacture these drugs have nothing to lose by any such deal, which makes them sound a bit high handed when they grouse about this situation.

Generosity is so damn easy when it's coming out of someone else's pocket.